NDLI: Synaptic Therapy in Alzheimer’s Disease: A CREB-centric Approach

Content Provider	Springer Nature Link
Author	Teich, Andrew F. Nicholls, Russell E. Puzzo, Daniela Fiorito, Jole Purgatorio, Rosa Fa’, Mauro Arancio, Ottavio
Copyright Year	2015
Abstract	Therapeutic attempts to cure Alzheimer’s disease (AD) have failed, and new strategies are desperately needed. Motivated by this reality, many laboratories (including our own) have focused on synaptic dysfunction in AD because synaptic changes are highly correlated with the severity of clinical dementia. In particular, memory formation is accompanied by altered synaptic strength, and this phenomenon (and its dysfunction in AD) has been a recent focus for many laboratories. The molecule cyclic adenosine monophosphate response element-binding protein (CREB) is at a central converging point of pathways and mechanisms activated during the processes of synaptic strengthening and memory formation, as CREB phosphorylation leads to transcription of memory-associated genes. Disruption of these mechanisms in AD results in a reduction of CREB activation with accompanying memory impairment. Thus, it is likely that strategies aimed at these mechanisms will lead to future therapies for AD. In this review, we will summarize literature that investigates 5 possible therapeutic pathways for rescuing synaptic dysfunction in AD: 4 enzymatic pathways that lead to CREB phosphorylation (the cyclic adenosine monophosphate cascade, the serine/threonine kinases extracellular regulated kinases 1 and 2, the nitric oxide cascade, and the calpains), as well as histone acetyltransferases and histone deacetylases (2 enzymes that regulate the histone acetylation necessary for gene transcription).
Starting Page	29
Ending Page	41
Page Count	13
File Format	PDF
ISSN	19337213
Journal	NeuroRX
Volume Number	12
Issue Number	1
e-ISSN	18787479
Language	English
Publisher	Springer US
Publisher Date	2015-01-10
Publisher Institution	American Society for Experimental NeuroTherapeutics
Publisher Place	Boston
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	cAMP/PKA/CREB cascade Calpains NO cascade HAT HDAC ERK1/2 MAP kinase pathway Neurosciences Neurology Neurosurgery Neurobiology
Content Type	Text
Resource Type	Article
Subject	Neurology (clinical) Pharmacology Pharmacology (medical)

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Synaptic Therapy in Alzheimer’s Disease: A CREB-centric Approach

Synaptic Therapy in Alzheimer’s Disease: A CREB-centric Approach

Inhibition of the PKCγ-ε Pathway Relieves from Meningeal Nociception in an Animal Model: An Innovative Perspective for Migraine Therapy?

Biometals and Their Therapeutic Implications in Alzheimer’s Disease

Epigenetics of Alzheimer’s Disease and Frontotemporal Dementia

β-amyloid Peptides and Amyloid Plaques in Alzheimer’s Disease

Astrocytes in Alzheimer’s disease

Neuroprotective strategies in Alzheimer’s disease

Targeting Synaptic Dysfunction in Alzheimer’s Disease Therapy

Synaptic Therapy in Alzheimer’s Disease: A CREB-centric Approach

Similar Documents

Synaptic Therapy in Alzheimer’s Disease: A CREB-centric Approach

Synaptic Therapy in Alzheimer’s Disease: A CREB-centric Approach

Inhibition of the PKCγ-ε Pathway Relieves from Meningeal Nociception in an Animal Model: An Innovative Perspective for Migraine Therapy?

Biometals and Their Therapeutic Implications in Alzheimer’s Disease

Epigenetics of Alzheimer’s Disease and Frontotemporal Dementia

β-amyloid Peptides and Amyloid Plaques in Alzheimer’s Disease

Astrocytes in Alzheimer’s disease

Neuroprotective strategies in Alzheimer’s disease

Targeting Synaptic Dysfunction in Alzheimer’s Disease Therapy

Synaptic Therapy in Alzheimer’s Disease: A CREB-centric Approach